How Combination Therapies Could Influence the Future of Fibrate Drugs

added blog Other

2026-08-17 10:14:21 -

According to a new report by Polaris Market Research, the global Fibrate Drugs market was valued at USD 1.5 billion in 2024 and is projected to reach USD 1.8 billion by 2034, expanding at a CAGR of 2.12% over the forecast period. Growth is underpinned by rising hyperlipidemia cases, expanding combination therapies for cardiovascular risk management, and accelerating research into...

0 Comments 0 Shares 471 Views 0 Reviews